ATXI (Avenue Therapeutics, Inc.) Book Value per Share
Avenue Therapeutics attracts leading neurobiologists through a flexible approach to R&D and long-term options. The change in BVPS on the GURU.Markets chart reflects asset dynamics, with the indicator holding at 1.64. The objectivity of these conclusions is ensured by automated data analysis, which, combined with late-stage molecule trials, creates significant potential for operating leverage.
Summary analytical data breakdowns for avenuetx.com (ATXI)
- share price and expert price forecast:
- business market valuation indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Avenue Therapeutics|ATXI - Long-Term Debt to Capital|Short-Term Debt to Equity Avenue Therapeutics, Inc.|ATXI - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Avenue Therapeutics, Inc.|ATXI - Long-Term Debt|Company Short-Term Debts Avenue Therapeutics|Quick Liquidity Indicator avenuetx.com
- earnings and multiples data:
General company analysis:ATXI - Avenue Therapeutics, Inc
Since Avenue Therapeutics is focused on clinical trials without active commercial products, the book value per common share becomes a key measure of financial stability. The current value of 1.64 reflects net assets minus liabilities, demonstrating to the investor the real value of the ownership stake and the company's margin of safety until its drugs reach the market.
Main competitors
BIIB: Accounting Value per Share|NBIX (Neurocrine Corp) - Equity per Share|RGC: Book Value per Share|AXSM - Net Assets per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share anavex.com|Accounting Value per Share CBLL (CeriBell)|Net Assets per Single Share PRTA (Prothena Corporation)|Book Value per Share ALEC (Alector)|Annexon Biosciences Inc. (ANNX) - Net Asset Value per Share|OMER - Net Assets per Single Share|NGNE (neurogene.com) - Equity per Share|ACIU (AC Immune SA) - Accounting Value per Share|Voyager Therapeutics Inc (VYGR) - Book Value per Share|NMRA (Neumora Therapeutics Inc) - Book Value per Share|Net Asset Value per Share Scilex Holding Company, Inc. SCLX|Accounting Value per Share TVGN (Tevogen Bio Holdings)|ACOG (alphacognition.com) - Accounting Value of a Share|Cognition Therapeutics - Accounting Value per Share|Book Price of a Share IKT (Inhibikase Therapeutics Inc)|Cassava - Book Value per Share|Accounting Value of a Share ASRT (Assertio Holdings, Inc.)|COYA: Book Value per Share|Net Asset Value per Share Vistagen (VTGN)|Net Assets per Single Share Ovid Therapeutics Inc|ABOS: Accounting Value of a Share|Book Value per Share CRVO|Book Value per Share alteritytherapeutics.com (ATHE)|Net Assets per Single Share Clene CLNN|PEPG (PepGen Inc) - Share Book Value|Jupiter Neurosciences Inc - Book Value per Share|Net Asset Value per Share Relmada Therapeutics Inc|ANVS (Annovis Bio Corp) - Accounting Value per Share|Grace Therapeutics (GRCE) - Book Value per Share|Accounting Value per Share AIFF|KLTO (ANEW Medical, Inc.) - Book Price of a Share|Book Value per Share NRSN|Net Assets per Share Reviva Pharmaceuticals Holdings Inc.|Book Value per Share MTVA (MetaVia)|NRXS - Accounting Value per Share|HSDT - Net Assets per Single Share|Net Assets per Share Passage Bio, Inc. PASG|NEUP: Book Value per Share|Minerva Neurosciences Inc (NERV) - Book Value per Share|Accounting Value per Share ATHA|ADXN (Addex) - Book Price of a Share|Accounting Value per Share ALZN (Alzamend Neuro, Inc.)|cyclerion.com - Equity per Share|Book Value per Share PTIX (Protagenic Therapeutics, Inc.)|Net Assets per Share Pasithea Therapeutics Corp (KTTA)|CRGT - Net Assets per Single Share|BCLI (BrainStorm Cell Therapeutics Inc.) - Equity per Share|CARA: Book Value per Share|Net Asset Value per Share chromocell.com (CHRO)|Accounting Value per Share ELYM|Book Value per Share Intra-Cellular|Net Assets per Single Share Longboard Pharma (LBPH)|MRNS (Marinus Pharma) - Accounting Value of a Share|Net Assets per Single Share NKGen Biotech, Inc. NKGN|neurobopharma.com (NRBO) - Net Asset Value per Share|Sage Therapeutics - Book Value per Share|SNPX - Book Value per Share|TRVN (Trevena, Inc) - Accounting Value per Share|VIGL (Vigil Neuroscience, Inc.) - Net Assets per Single Share|WENA (Anew Medical) - Book Value per Share|Net Asset Value per Share cerevel.com CERE